{"DataElement":{"publicId":"12291814","version":"1","preferredName":"Patient CDK4/6 Inhibitor Use Indicator","preferredDefinition":"Response indicating whether patient used CDK4 or 6 inhibitor.","longName":"CDK4_6_USE_IND","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"12291813","version":"1","preferredName":"Patient CDK4/6 Inhibition Use","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Inhibition of cyclin-dependent kinases 4 and 6 pathway activity to prevent proliferation of cancer cells and tumor growth.:To put into action or service.","longName":"12291812v1.00:3433517v1.00","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"12291812","version":"1","preferredName":"Patient CDK4/6 Inhibition","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Inhibition of cyclin-dependent kinases 4 and 6 pathway activity to prevent proliferation of cancer cells and tumor growth.","longName":"C16960:C116938","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"CDK4/6 Inhibition","conceptCode":"C116938","definition":"Inhibition of cyclin-dependent kinases 4 and 6 pathway activity to prevent proliferation of cancer cells and tumor growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F17AF724-A928-50AF-E053-731AD00ABC1D","latestVersionIndicator":"Yes","beginDate":"2023-01-04","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-04","modifiedBy":"TSESU","dateModified":"2023-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3433517","version":"1","preferredName":"Use","preferredDefinition":"To put into action or service.","longName":"C95018","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Use","conceptCode":"C95018","definition":"To put into action or service.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCF40A97-87A9-DFE1-E040-BB89AD431915","latestVersionIndicator":"Yes","beginDate":"2012-04-05","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-04-05","modifiedBy":"ONEDATA","dateModified":"2012-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F17AF724-A929-50AF-E053-731AD00ABC1D","latestVersionIndicator":"Yes","beginDate":"2023-01-04","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-04","modifiedBy":"TSESU","dateModified":"2023-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"CDK4_6_PREV_USE_IND","type":"Context Short Name","context":"ECOG-ACRIN"},{"name":"CDK4_6_INT_USE_IND","type":"Context Short Name","context":"ECOG-ACRIN"},{"name":"CDK4_6_INIT_USE_IND","type":"Context Short Name","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Has the patient previously used CDK4/6i?","url":null,"context":"NRG"},{"name":"ECOG-ACRIN - 1","type":"Alternate Question Text","description":"Has the patient been previously treated with any of the following CDK4/6 inhibitors: Palbociclib or Ibrance, Ribociclib or Kisqali, and Abemaciclib or Verzenio?","url":null,"context":"ECOG-ACRIN"},{"name":"ECOG-ACRIN - 2","type":"Alternate Question Text","description":"Has the patient initiated any of the CDK4/6 inhibitors (Palbociclib or Ibrance, Ribociclib or Kisqali, Abemaciclib or Verzenio) within 30 days prior to consenting to Step 0 or have they received a prescription order with stated intent to initiate within 30 days following Step 0 consent?","url":null,"context":"ECOG-ACRIN"},{"name":"ECOG-ACRIN - 3","type":"Alternate Question Text","description":"Did patient initiate their CDK 4/6 inhibitors within 30 days of the date of Step 0 registration?","url":null,"context":"ECOG-ACRIN"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Does the patient intend to receive a CDK4/6 inhibitor?","url":null,"context":"NRG"},{"name":"ECOG-ACRIN - 4","type":"Alternate Question Text","description":"Has the patient initiated their CDK4/6 inhibitor (Palbociclib or Ibrance, Ribociclib or Kisqali, Abemaciclib or Verzenio) provided/supplied in single agent blister packs, within 30 days prior to consenting to Step 0 or have they received a prescription order with stated intent to initiate within 30 days following Step 0 consent?","url":null,"context":"ECOG-ACRIN"},{"name":"ECOG-ACRIN - 5","type":"Alternate Question Text","description":"Did the patient initiate their CDK4/6 inhibitor (blister pack) within 30 days of date of Step 0 registration?","url":null,"context":"ECOG-ACRIN"},{"name":"NRG CRF Text 2","type":"Alternate Question Text","description":"Did the patient have prior therapy with CDK4/6 inhibition?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F17B0310-F083-51D1-E053-731AD00A21D6","latestVersionIndicator":"Yes","beginDate":"2023-01-04","endDate":null,"createdBy":"TSESU","dateCreated":"2023-01-04","modifiedBy":"TYRRELLM","dateModified":"2023-10-23","changeDescription":null,"administrativeNotes":"10.23.23_Added AQT per request ticket CADSR0002989_mmt","unresolvedIssues":null,"deletedIndicator":"No"}}